The Need for Guidelines Related to Patients with GI, Dermatologic Symptoms

In the third iteration of their HCPLive Special Report series, dermatologist Raj Chovatiya, MD, PhD, and gastroenterologist Adelina Hung, MD, the subject of cross-specialty collaboration related to immune-mediated inflammatory diseases in gastroenterology and dermatology is further explored. Hung serves as director of the IBD Program at Sinai Health System Chicago and a clinical assistant professor at the Rosalind Franklin University Medical School. Chovatiya is a clinical associate professor for Rosalind Franklin University Chicago Medical School and the Center for Medical Dermatology and Immunology Research's director.

During this discussion, Hung and Chovatiya discuss unmet needs in gastroenterology (GI) and dermatology. Hung emphasized the importance of cross-disciplinary training to improve early and accurate diagnosis of comorbid diseases. Chovatiya highlighted the need for standardized guidelines and protocols for co-managing patients with multiple diseases. Both speakers concur on the necessity of addressing disparities in care, particularly among underserved racial and ethnic groups.

They also discuss the need for comprehensive treatment plans and the importance of treating patients as whole-body systems rather than individual organs. The conversation regarding gut health and its relationship with skin health concludes with optimism about future clinical trials that include diverse patient populations and the training of young doctors to recognize findings across specialties.

Editors’ note: Chovatiya has reported serving as an advisor, consultant, speaker, and/or investigator for AbbVie, Amgen, Apogee Therapeutics, Arcutis, Argenx, ASLAN Pharmaceuticals, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Dermavant, Eli Lilly and Company, FIDE, Formation Bio, Galderma, Genentech, GSK, Incyte, LEO Pharma, L’Oréal, Nektar Therapeutics, Novartis, Opsidio, Pfizer Inc, Regeneron, RAPT, Sanofi, Sitryx, and UCB. Hung has no relevant disclosures.

This summary was created with the help of artificial intelligence tools.